Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Using electrical stimulation to reduce cough after lung cancer surgery

Official title: Director of Oncology Department, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

Run by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine · NCT06548711 · Data updated 2026-11-12

This study is testing whether a new electrical treatment can help lung cancer patients reduce their cough after surgery.

More Lung Cancer trials

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment84 (estimated)
SponsorFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Academic / other
Locations1 site (Tianjin, Tianjin Municipality)
StatusRecruiting
StartedApril 17, 2024
Main results expectedApril 17, 2026
Study endsJune 17, 2026
Registry record updatedSeptember 8, 2025
Trial IDNCT06548711 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 80 who have undergone radical lung cancer surgery and have experienced persistent dry cough for at least two weeks.

Probably not a fit

Patients with acute respiratory diseases, pneumonia, or severe systemic conditions may not benefit from this treatment.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of Transcutaneous Acupoint Electrical Stimulation (TAES) in alleviating postoperative cough in lung cancer patients. A total of 120 patients who have undergone lung cancer surgery will be enrolled and monitored for changes in cough symptoms using various scoring systems. The study employs a prospective, randomized, blind, and controlled design to ensure robust evidence for the treatment's efficacy and safety. Data will be collected and analyzed to evaluate the overall effectiveness of TAES in improving patients' quality of life post-surgery.

Why it matters

Potential benefit: If successful, this treatment could provide a non-pharmacological option to significantly improve cough symptoms and quality of life for postoperative lung cancer patients.

How similar studies have gone: While the specific approach of TAES for postoperative cough is novel, similar non-pharmacological interventions have shown promise in other studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 18 and 80 years old - Surgery performed under general anesthesia for radical resection of lung cancer or lung cancer resection combined with lymph node dissection.
* Pathological confirmation of primary lung cancer after surgery.
* Duration of persistent dry cough after lung surgery ≥2 weeks.
* Consciousness, ability to express opinions clearly, and voluntary signing of informed consent.

Exclusion Criteria:

* Patients diagnosed with acute respiratory system diseases within 1 month.
* Patients diagnosed with pneumonia based on chest X-ray.
* Patients with a history of asthma or tuberculosis.
* Patients with uncontrolled hyperthyroidism, severe hypertension, heart disease, systemic infection, coagulation disorders (hypercoagulable state or bleeding tendency), or other severe systemic diseases.
* Patients who have used steroid drugs within the past 3 months.
* Patients who have taken angiotensin-converting enzyme inhibitors (ACEIs) within the past 6 months.
* Patients with surgical incisions, skin allergies, wounds, or infections in the treatment area.
* Patients who cannot tolerate transcutaneous acupoint electrical stimulation or withdraw during the procedure.
* Patients with contraindications to transcutaneous electrical stimulation or implanted electrophysiological devices.
* Patients who are pregnant or breastfeeding.

Where it's running

  • First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
    Tianjin, Tianjin Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.